The Search for Biomarkers in Endometriosis: a Long and Windy Road
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
34159571
DOI
10.1007/s43032-021-00668-2
PII: 10.1007/s43032-021-00668-2
Knihovny.cz E-zdroje
- Klíčová slova
- Biomarker, CA-125, Endometriosis, Human epididymis protein 4, Immunology, MicroRNA, Stem cells,
- MeSH
- biologické markery MeSH
- endometrióza * diagnóza patologie MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- biologické markery MeSH
Endometriosis is a complex and chronic estrogen-dependent disease, affecting a significant proportion of women of reproductive age. Despite the long interest and extensive research, the pathogenesis of the disease is still debated. Although available non-invasive diagnostic methods have adequate accuracy, an invasive approach by laparoscopy is often necessary to obtain histological confirmation. In this scenario, the search for an accurate, reliable, cost-effective, clinically applicable non-invasive biomarker plays a crucial role in a potentially early diagnosis and, in this way, shape the future management of the disease. Considering these elements, the current review aims to summarize the most significant and novel results about biomarkers for the diagnosis and follow-up of women affected by endometriosis.
Biomedical Centre Faculty of Medicine in Plzen Charles University Pilsen Czech Republic
Department of Histology and Embryology Faculty of Medicine Charles University Pilsen Czech Republic
Department of Obstetrics and Gynecology AOUI Verona University of Verona Verona Italy
Department of Pathology University of Louisville Louisville KY USA
Institute of Sexology 1st Faculty of Medicine Charles University Prague Czech Republic
Zobrazit více v PubMed
Missmer SA, Cramer DW. The epidemiology of endometriosis. Obstet Gynecol Clin N Am. 2003;30:1–19 vii. DOI
Baldi A, Campioni M, Signorile PG. Endometriosis: pathogenesis, diagnosis, therapy and association with cancer (review). Oncol Rep. 2008;19:843–6. PubMed
Laganà AS, Garzon S, Götte M, Viganò P, Franchi M, Ghezzi F, et al. The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci. 2019;20(22):5615. DOI PMC
Sundqvist J, Andersson KL, Scarselli G, Gemzell-Danielsson K, Lalitkumar PG. Expression of adhesion, attachment and invasion markers in eutopic and ectopic endometrium: a link to the aetiology of endometriosis. Hum Reprod. 2012;27(9):2737–46. PubMed DOI
Garzon S, Laganà AS, Barra F, Casarin J, Cromi A, Raffaelli R, et al. Aromatase inhibitors for the treatment of endometriosis: a systematic review about efficacy, safety and early clinical development. Expert Opin Investig Drugs. 2020;29:1377–88. PubMed DOI
Riemma G, Laganà AS, Schiattarella A, Garzon S, Cobellis L, Autiero R, et al. Ion channels in the pathogenesis of endometriosis: a cutting-edge point of view. Int J Mol Sci. 2020;21(3):1114. DOI PMC
Della Corte L, Noventa M, Ciebiera M, Magliarditi M, Sleiman Z, Karaman E, et al. Phytotherapy in endometriosis: an up-to-date review. J Complement Integr Med. 2020;17(3):/j/jcim.2020.17.issue-3/jcim-2019-0084/jcim-2019-0084.xml. DOI
Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382:1244–56. PubMed DOI
Garzon S, Laganà AS, Barra F, Casarin J, Cromi A, Raffaelli R, et al. Novel drug delivery methods for improving efficacy of endometriosis treatments. Expert Opin Drug Deliv. 2020;27:1–13. https://doi.org/10.1080/17425247.2021.1829589 . DOI
Ghai V, Jan H, Shakir F, Haines P, Kent A. Diagnostic delay for superficial and deep endometriosis in the United Kingdom. J Obstet Gynaecol. 2020;40(1):83–9. PubMed DOI
Anastasiu CV, Moga MA, Elena Neculau A, Bălan A, Scârneciu I, Dragomir RM, et al. Biomarkers for the noninvasive diagnosis of endometriosis: state of the art and future perspectives. Int J Mol Sci. 2020;21(5):1750. DOI PMC
Králíčková M, Vetvicka V. Endometriosis and ovarian cancer. World J Clin Oncol. 2014;5:800–5. PubMed DOI PMC
Hudson QJ, Ashjaei K, Perricos A, Kuessel L, Husslein H, Wenzl R, et al. Endometriosis patients show an increased M2 response in the peritoneal CD14+low/CD68+low macrophage subpopulation coupled with an increase in the T-helper 2 and T-regulatory cells. Reprod Sci. 2020;27:1920–31. PubMed DOI
Ottolina J, Bartiromo L, Dolci C, Salmeri N, Schimberni M, Villanacci R, et al. Assessment of coagulation parameters in women affected by endometriosis: validation study and systematic review of the literature. Diagnostics (Basel). 2020;10:567. DOI
Berbic M, Fraser IS. Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol. 2011;88:149–55. PubMed DOI
Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, Taketani Y. Lymphocytes in endometriosis. Am J Reprod Immunol. 2011;65:1–10. PubMed DOI
Gueuvoghlanian-Silva BY, Hernandes C, Correia RP, Podgaec S. Deep infiltrating endometriosis and activation and memory surface markers and cytokine expression in isolated Treg cells. Reprod Sci. 2020;27:599–610. PubMed DOI
Meng Q, Sun W, Jiang J, Fletcher NM, Diamond MP, Saed GM. Identification of common mechanisms between endometriosis and ovarian cancer. J Assist Reprod Genet. 2011;28:917–23. PubMed DOI PMC
Ponandai-Srinivasan S, Saare M, Boggavarapu NR, Frisendahl C, Ehrström S, Riethmüller C, et al. Syndecan-1 modulates the invasive potential of endometrioma via TGF-β signalling in a subgroup of women with endometriosis. Hum Reprod. 2020;35:2280–93. PubMed DOI
Karamian A, Paktinat S, Esfandyari S, Nazarian H, Ali Ziai S, Zarnani AH, et al. Pyrvinium pamoate induces in-vitro suppression of IL-6 and IL-8 produced by human endometriotic stromal cells. Hum Exp Toxicol. 2021;40:649–60. PubMed DOI
Gica N, Panaitescu AM, Iancu G, Botezatu R, Peltecu G, Gica C. The role of biological markers in predicting infertility associated with non-obstructive endometriosis. Ginekol Pol. 2020;91:189–92. PubMed DOI
Shimizu K, Kamada Y, Sakamoto A, Matsuda M, Nakatsuka M, Hiramatsu Y. High expression of high-mobility group box 1 in menstrual blood: implications for endometriosis. Reprod Sci. 2017;24:1532–7. PubMed DOI
Santulli P, Borghese B, Chouzenoux S, Vaiman D, Borderie D, Streuli I, et al. Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis. Hum Reprod. 2012;27:2001–9. PubMed DOI
Miller JE, Monsanto SP, Ahn SH, Khalaj K, Fazleabas AT, Young SL, et al. Interleukin-33 modulates inflammation in endometriosis. Sci Rep. 2017;7:17903. PubMed DOI PMC
Dorien O, Waelkens E, Vanhie A, Peterse D, Fassbender A, D’Hooghe T. The use of antibody arrays in the discovery of new plasma biomarkers for endometriosis. Reprod Sci. 2020;27:751–62. DOI
Guo M, Bafligil C, Tapmeier T, Hubbard C, Manek S, Shang C, et al. Mass cytometry analysis reveals a distinct immune environment in peritoneal fluid in endometriosis: a characterisation study. BMC Med. 2020;18:3. PubMed DOI PMC
Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, et al. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res. 2013;19:1213–24. PubMed DOI PMC
Siufi Neto J, Kho RM, Siufi DF, Baracat EC, Anderson KS, Abrão MS. Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer. J Minim Invasive Gynecol. 2014;21:55–63. PubMed DOI
Papari E, Noruzinia M, Kashani L, Foster WG. Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative real-time polymerase chain reaction. Fertil Steril. 2020;113:1232–41. PubMed DOI
Gao S, Liu S, Gao ZM, Deng P, Wang DB. Reduced microRNA-451 expression in eutopic endometrium contributes to the pathogenesis of endometriosis. World J Clin Cases. 2019;7:2155–64. PubMed DOI PMC
Chen S, Luo Y, Cui L, Yang Q. miR-96-5p regulated TGF-β/SMAD signaling pathway and suppressed endometrial cell viability and migration via targeting TGFBR1. Cell Cycle. 2020;19:1740–53. PubMed DOI PMC
Vanhie A, O D, Peterse D, Beckers A, Cuéllar A, Fassbender A, et al. Plasma miRNAs as biomarkers for endometriosis. Hum Reprod. 2019;34:1650–60. PubMed DOI PMC
Madjid TH, Ardiansyah DF, Permadi W, Hernowo B. Expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in endometriosis menstrual blood. Diagnostics (Basel). 2020;10(6):364. DOI
Bostanci Durmus A, Dincer Cengiz S, Yılmaz H, Candar T, Gursoy AY, Sinem CG. The levels of matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in different stages of endometriosis. J Obstet Gynaecol. 2019;39:991–5. PubMed DOI
Weigel MT, Krämer J, Schem C, Wenners A, Alkatout I, Jonat W, et al. Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol. 2012;160:74–8. PubMed DOI
Liu C, Chen Y, Chen M, Mao X, Dong B, Sun P. A novel non-invasive molecular biomarker in ovarian endometriosis: estrogen-related receptor α. Arch Gynecol Obstet. 2020;302:405–14. PubMed DOI
Proestling K, Wenzl R, Yotova I, Hauser C, Husslein H, Kuessel L. Investigating selected adhesion molecules as urinary biomarkers for diagnosing endometriosis. Reprod BioMed Online. 2020;40:555–8. PubMed DOI
Kocbek V, Vouk K, Mueller MD, Rižner TL, Bersinger NA. Elevated glycodelin-A concentrations in serum and peritoneal fluid of women with ovarian endometriosis. Gynecol Endocrinol. 2013;29:455–9. PubMed DOI
Drosdzol-Cop A, Skrzypulec-Plinta V. Selected cytokines and glycodelin A levels in serum and peritoneal fluid in girls with endometriosis. J Obstet Gynaecol Res. 2012;38:1245–53. PubMed DOI
Li Y, Chen Q. Circulating non-coding RNAs as non-invasive diagnostic markers of endometriosis: a comprehensive meta-analysis. Arch Gynecol Obstet. 2019;300:1099–112. PubMed DOI
Joseph S, Mahale SD. Endometriosis knowledgebase: a gene-based resource on endometriosis. Database (Oxford). 2019;2019:baz062. DOI
Ortiz-Muñoz B, Aznar-Oroval E, García García A, Covisa Peris A, Perez Ballestero P, Sanchez Yepes M, et al. HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer. Tumour Biol. 2014;35:7249–58. PubMed DOI
Jacob F, Meier M, Caduff R, Goldstein D, Pochechueva T, Hacker N, et al. No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecol Oncol. 2011;121:487–91. PubMed DOI
Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, et al. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer. 2009;100:1315–9. PubMed DOI PMC
Zapardiel I, Gorostidi M, Ravaggi A, Allende MT, Silveira M, Abehsera D, et al. Utility serum marker HE4 for the differential diagnosis between endometriosis and adnexal malignancy. Int J Gynecol Cancer. 2016;26:52–5. PubMed DOI
Bandiera E, Zanotti L, Fabricio AS, Bucca E, Squarcina E, Romani C, et al. Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. Clin Chem Lab Med. 2013;51:1815–24. PubMed DOI
Bast RC Jr, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB. CA 125: the past and the future. Int J Biol Markers. 1998;13:179–87. PubMed DOI
Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68(5):1331–7. PubMed DOI PMC
Králíčková M, Losan P, Vetvicka V. Endometriosis and cancer. Womens Health (Lond). 2014;10:591–7. DOI
Pittaway DE, Fayez JA. The use of CA-125 in the diagnosis and management of endometriosis. Fertil Steril. 1986;46:790–5. PubMed DOI
Toki T, Kubota J, Lu X, Nakayama K. Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation. Acta Obstet Gynecol Scand. 2000;79:771–6. PubMed
Sütcü HK, Celik GIT, Akpak YK, Akar ME, Taşkın Ö, Ozdem S, et al. The value of CA-125, CA 19-9, Interleukin-6, Interleukin-8 and hsCRP in the diagnosis of endometriosis. Acta Medica Mediterranea. 2015;31:793–9.
Shinmura H, Yoneyama K, Harigane E, Tsunoda Y, Fukami T, Matsushima T, et al. Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma. Int J Gynecol Cancer. 2020;30:831–6. PubMed DOI PMC
Li M, Tan J, Zhang Y, Ai C, Wang H, Zhang H, et al. Assessing CT imaging features combined with CEA and CA125 levels to identify endometriosis-associated ovarian cancer. Abdom Radiol (NY). 2020;46:2367–75. https://doi.org/10.1007/s00261-020-02571-x . DOI
Jing X, Li C, Sun J, Peng J, Dou Y, Xu X, et al. Systemic inflammatory response markers associated with infertility and endometrioma or uterine leiomyoma in endometriosis. Ther Clin Risk Manag. 2020;16:403–12. PubMed DOI PMC
Ding S, Lin Q, Zhu T, Li T, Zhu L, Wang J, et al. Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis? BMC Womens Health. 2019;19:169. PubMed DOI PMC
Liu S, Zhou J, Wen J. Expression and significance of CD133 and ABCG2 in endometriosis. Clin Exp Obstet Gynecol. 2015;42:771–5. PubMed DOI
Tempest N, Maclean A, Hapangama DK. Endometrial stem cell markers: current concepts and unresolved questions. Int J Mol Sci. 2018;19(10):3240. DOI PMC
Kao AP, Wang KH, Chang CC, Lee JN, Long CY, Chen HS, et al. Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril. 2011;95:1308–15.e1. PubMed DOI
Chan RW, Ng EH, Yeung WS. Identification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis. Am J Pathol. 2011;178:2832–44. PubMed DOI PMC
Liu Y, Liang S, Yang F, Sun Y, Niu L, Ren Y, et al. Biological characteristics of endometriotic mesenchymal stem cells isolated from ectopic lesions of patients with endometriosis. Stem Cell Res Ther. 2020;11:346. PubMed DOI PMC
Valentijn AJ, Palial K, Al-Lamee H, Tempest N, Drury J, Von Zglinicki T, et al. SSEA-1 isolates human endometrial basal glandular epithelial cells: phenotypic and functional characterization and implications in the pathogenesis of endometriosis. Hum Reprod. 2013;28:2695–708. PubMed DOI
Song Y, Xiao L, Fu J, Huang W, Wang Q, Zhang X, et al. Increased expression of the pluripotency markers sex-determining region Y-box 2 and Nanog homeobox in ovarian endometriosis. Reprod Biol Endocrinol. 2014;12:42. PubMed DOI PMC
Shariati F, Favaedi R, Ramazanali F, Ghoraeian P, Afsharian P, Aflatoonian B, et al. Increased expression of stemness genes REX-1, OCT-4, NANOG, and SOX-2 in women with ovarian endometriosis versus normal endometrium: a case-control study. Int J Reprod Biomed. 2019;16:ijrm.v16i12.3684. PubMed PMC
Chang JH, Au HK, Lee WC, Chi CC, Ling TY, Wang LM, et al. Expression of the pluripotent transcription factor OCT4 promotes cell migration in endometriosis. Fertil Steril. 2013;99:1332–1339.e5. PubMed DOI
Zhang Y, Eades G, Yao Y, Li Q, Zhou Q. Estrogen receptor α signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem. 2012;287(49):41514–22. PubMed DOI PMC
Yang L, Luo L, Ji W, Gong C, Wu D, Huang H, et al. Effect of low dose bisphenol A on the early differentiation of human embryonic stem cells into mammary epithelial cells. Toxicol Lett. 2013;218:187–93. PubMed DOI
Abramiuk M, Grywalska E, Korona-Glowniak I, Niedzwiedzka-Rystwej P, Polak G, Kotarski J, et al. CD200 and CD200R expression on peripheral blood lymphocytes and serum CD200 concentration as a new marker of endometriosis. J Clin Med. 2020;9. https://doi.org/10.3390/jmc9093035 .
Nothnick WB. MicroRNAs and endometriosis: distinguishing drivers from passengers in disease pathogenesis. Semin Reprod Med. 2017;35:173–80. PubMed DOI PMC
Li Y, Chen Q. Circulating non-coding RNA as non-invasive diagnostic markers of endometriosis: a comprehensive meta-analysis. Arch Gynecol Obstet. 2019;300:1099–112. PubMed DOI
Papari E, Noruzinia M, Kashani L, Foster WG. Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative re3al-time polymerase chain reaction. Fertil Steril. 2020;113:1232–41. PubMed DOI
Liu C, Chen YJ, Chen M, Mao XD, Dong BH, Sun PM. A novel non-invasive molecular biomarker in ovarian endometriosis: estrogen-related receptor A. Arch Gynecol Obstet. 2020;302:405–14. PubMed DOI
Endometriosis and gynaecological cancers: molecular insights behind a complex machinery